Comment on "Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock" by Dellinger et al.
D F
DF
Zandstra
P H J
PH
van der Voort
D018890:Chemoprevention / Q000592:standards; D019317:Evidence-Based Medicine / Q000592:standards*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010437:Peptic Ulcer / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D018805:Sepsis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D012772:Shock, Septic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D013312:Stress, Physiological / Q000503:physiopathology
D006635:Histamine H2 Antagonists